Antacids Market

Antacids are the most commonly used product for treating heartburn discomfort. and because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. and having some food in your stomach may actually prolong an antacid?s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.

Antacids Market contains market size and forecasts of Antacids in global, including the following market information:

• Global Antacids Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Antacids Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Antacids companies in 2021 (%)
• The global Antacids market was valued at 6112 million in 2021 and is projected to reach US$ 7169.7 million by 2028, at a CAGR of 2.3% during the forecast period.
• The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-Systemic Antacids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antacids include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter & Gamble, GlaxoSmithKline, Johnson & Johnson and CONBA, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Antacids manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antacids Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antacids Market Segment Percentages, by Type, 2021 (%)

• Non-Systemic Antacids
• Systemic Antacids

Global Antacids Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antacids Market Segment Percentages, by Application, 2021 (%)

• Rx Drug
• OTC Drug

Global Antacids Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Antacids Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Antacids revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Antacids revenues share in global market, 2021 (%)
• Key companies Antacids sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Antacids sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Takeda Pharmaceutical
• Pfizer
• Reckitt Benckiser
• Bayer
• Procter & Gamble
• GlaxoSmithKline
• Johnson & Johnson
• CONBA
• Xiuzheng Pharma
• Sanofi
• Bausch Health
• CR SANJIU
• Novartis